Pharming Group Nv Stock Probability of Future Stock Price Finishing Under 7.45
| PHAR Stock | USD 9.32 0.05 0.54% |
Pharming |
Pharming Group Target Price Odds to finish below 7.45
The tendency of Pharming Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 7.45 or more in 90 days |
| 9.32 | 90 days | 7.45 | about 9.57 |
Based on a normal probability distribution, the odds of Pharming Group to drop to $ 7.45 or more in 90 days from now is about 9.57 (This Pharming Group NV probability density function shows the probability of Pharming Stock to fall within a particular range of prices over 90 days) . Probability of Pharming Group NV price to stay between $ 7.45 and its current price of $9.32 at the end of the 90-day period is about 89.05 .
Given the investment horizon of 90 days Pharming Group NV has a beta of -0.93 indicating Additionally Pharming Group NV has an alpha of 0.5693, implying that it can generate a 0.57 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pharming Group Price Density |
| Price |
Predictive Modules for Pharming Group
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharming Group NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pharming Group Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharming Group is not an exception. The market had few large corrections towards the Pharming Group's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharming Group NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharming Group within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.57 | |
β | Beta against Dow Jones | -0.93 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | 0.10 |
Pharming Group Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharming Group for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharming Group NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharming Group NV had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 245.32 M. Net Loss for the year was (9.55 M) with profit before overhead, payroll, taxes, and interest of 188.06 M. | |
| Pharming Group NV currently holds about 189.96 M in cash with (17.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.91. | |
| Pharming Group NV has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug |
Pharming Group Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharming Stock often depends not only on the future outlook of the current and potential Pharming Group's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharming Group's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 657 M | |
| Cash And Short Term Investments | 213.4 M |
Pharming Group Technical Analysis
Pharming Group's future price can be derived by breaking down and analyzing its technical indicators over time. Pharming Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharming Group NV. In general, you should focus on analyzing Pharming Stock price patterns and their correlations with different microeconomic environments and drivers.
Pharming Group Predictive Forecast Models
Pharming Group's time-series forecasting models is one of many Pharming Group's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharming Group's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pharming Group NV
Checking the ongoing alerts about Pharming Group for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharming Group NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pharming Group NV had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 245.32 M. Net Loss for the year was (9.55 M) with profit before overhead, payroll, taxes, and interest of 188.06 M. | |
| Pharming Group NV currently holds about 189.96 M in cash with (17.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.91. | |
| Pharming Group NV has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug |
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.